,i #aaith ,,congress #ast ,session ,h4 ,r4 #bdej ,,in ,,the ,,house ,,of ,,representatives ,march #bg1 #bjbe,ms4 ,mc,donald ,rivet 7for herself1 ,mr4 ,carter of ,georgia1 ,mr4 ,menendez1 and ,mr4 ,james7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,education and ,workforce1 and ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,public ,health ,service ,act1 the ,employee ,retirement ,income ,security ,act of #aigd1 and the ,internal ,revenue ,code of #aihd to increase oversight of pharmacy benefit management services1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,prescription ,drug ,transparency and ,affordability ,act4 #b4 ,oversight of pharmacy benefit management services 7a7 ,public ,health ,service ,act ,title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg et seq47 is amended-- 7#a7 in part ,d 7#db ,u4,s4,c4 #cjj;gg-#aaa et seq471 by adding at the end the following new section3 #bgii;,a-#aa4 ,oversight of entities that provide pharmacy benefit management services 7a7 ,in general ,for plan years beginning on or after the date that is #cj months after the date of enactment of this section 7referred to in this subsection and subsection 7b7 as the effective date71 a group health plan or a health insurance issuer offering group health insurance coverage1 or an entity providing pharmacy benefit management services on behalf of such a plan or issuer1 shall not enter into a contract1 including an extension or renewal of a contract1 entered into on or after the effective date1 with an applicable entity unless such applicable entity agrees to-- 7#a7 not limit or delay the disclosure of information to the group health plan 7including such a plan offered through a health insurance issuer7 in such a manner that prevents an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage from making the reports described in subsection 7b72 and 7#b7 provide the entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer relevant information necessary to make the reports described in subsection 7b74 7b7 ,reports 7#a7 ,in general ,for plan years beginning on or after the effective date1 in the case of any contract between a group health plan or a health insurance issuer offering group health insurance coverage offered in connection with such a plan and an entity providing pharmacy benefit management services on behalf of such plan or issuer1 including an extension or renewal of such a contract1 entered into on or after the effective date1 the entity providing pharmacy benefit management services on behalf of such a group health plan or health insurance issuer1 not less frequently than every #f months 7or1 at the request of a group health plan1 not less frequently than quarterly1 and under the same conditions1 terms1 and cost of the semiannual report under this subsection71 shall submit to the group health plan a report in accordance with this section4 ,each such report shall be made available to such group health plan in plain language1 in a machine-readable format1 and as the ,secretary may determine1 other formats4 ,each such report shall include the information described in paragraph 7#b74 7#b7 ,information described ,for purposes of paragraph 7#a71 the information described in this paragraph is1 with respect to drugs covered by a group health plan or group health insurance coverage offered by a health insurance issuer in connection with a group health plan during each reporting period-- 7,a7 in the case of a group health plan that is offered by a specified large employer or that is a specified large plan1 and is not offered as health insurance coverage1 or in the case of health insurance coverage for which the election under paragraph 7#c7 is made for the applicable reporting period-- 7i7 a list of drugs for which a claim was filed and1 with respect to each such drug on such list-- 7,i7 the contracted compensation paid by the group health plan or health insurance issuer for each covered drug 7identified by the ,national ,drug ,code7 to the entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan or health insurance issuer2 7,,ii7 the contracted compensation paid to the pharmacy1 by any entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan or health insurance issuer1 for each covered drug 7identified by the ,national ,drug ,code72 7,,iii7 for each such claim1 the difference between the amount paid under subclause 7,i7 and the amount paid under subclause 7,,ii72 7,,iv7 the proprietary name1 established name or proper name1 and ,national ,drug ,code2 7,v7 for each claim for the drug 7including original prescriptions and refills7 and for each dosage unit of the drug for which a claim was filed1 the type of dispensing channel used to furnish the drug1 including retail1 mail order1 or specialty pharmacy2 7,,vi7 with respect to each drug dispensed1 for each type of dispensing channel 7including retail1 mail order1 or specialty pharmacy7-- 7aa7 whether such drug is a brand name drug or a generic drug1 and-- 7,,aa7 in the case of a brand name drug1 the wholesale acquisition cost1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7,,bb7 in the case of a generic drug1 the average wholesale price1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7bb7 the total number of-- 7,,aa7 prescription claims 7including original prescriptions and refills72 7,,bb7 participants and beneficiaries for whom a claim for such drug was filed through the applicable dispensing channel2 7,,cc7 dosage units and dosage units per fill of such drug2 and 7,,dd7 days supply of such drug per fill2 7,,vii7 the net price per course of treatment or single fill1 such as a #cj-;day supply or #ij-;day supply to the plan or coverage after rebates1 fees1 alternative discounts1 or other remuneration received from applicable entities2 7,,viii7 the total amount of out-of-pocket spending by participants and beneficiaries on such drug1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan or coverage1 or for which no claim is submitted under the plan or coverage2 7,,ix7 the total net spending on the drug2 7,x7 the total amount received1 or expected to be received1 by the plan or issuer from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 7,,xi7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of such drug or spending on such drug2 and 7,,xii7 to the extent feasible1 information on the total amount of remuneration for such drug1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer71 to the participants and beneficiaries enrolled in such plan or coverage2 7ii7 a list of each therapeutic class 7as defined by the ,secretary7 for which a claim was filed under the group health plan or health insurance coverage during the reporting period1 and1 with respect to each such therapeutic class-- 7,i7 the total gross spending on drugs in such class before rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,ii7 the net spending in such class after such rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,iii7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of drugs or drug spending2 7,,iv7 the average net spending per #cj-;day supply and per #ij-;day supply by the plan or by the issuer with respect to such coverage and its participants and beneficiaries1 among all drugs within the therapeutic class for which a claim was filed during the reporting period2 7,v7 the number of participants and beneficiaries who filled a prescription for a drug in such class1 including the ,national ,drug ,code for each such drug2 7,,vi7 if applicable1 a description of the formulary tiers and utilization mechanisms 7such as prior authorization or step therapy7 employed for drugs in that class2 and 7,,vii7 the total out-of-pocket spending under the plan or coverage by participants and beneficiaries1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan or coverage or for which no claim is submitted under the plan or coverage2 7iii7 with respect to any drug for which gross spending under the group health plan or health insurance coverage exceeded #aj1jjj during the reporting period or1 in the case that gross spending under the group health plan or coverage exceeded #aj1jjj during the reporting period with respect to fewer than #ej drugs1 with respect to the #ej prescription drugs with the highest spending during the reporting period-- 7,i7 a list of all other drugs in the same therapeutic class as such drug2 7,,ii7 if applicable1 the rationale for the formulary placement of such drug in that therapeutic category or class1 selected from a list of standard rationales established by the ,secretary1 in consultation with stakeholders2 and 7,,iii7 any change in formulary placement compared to the prior plan year2 and 7iv7 in the case that such plan or issuer 7or an entity providing pharmacy benefit management services on behalf of such plan or issuer7 has an affiliated pharmacy or pharmacy under common ownership1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost sharing assistance incentives funded by an entity providing pharmacy benefit services-- 7,i7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in the plan or coverage to fill prescriptions at mail order1 specialty1 or retail pharmacies2 7,,ii7 the percentage of total prescriptions dispensed by such pharmacies to participants or beneficiaries in such plan or coverage2 and 7,,iii7 a list of all drugs dispensed by such pharmacies to participants or beneficiaries enrolled in such plan or coverage1 and1 with respect to each drug dispensed-- 7aa7 the amount charged1 per dosage unit1 per #cj-;day supply1 or per #ij-;day supply 7as applicable7 to the plan or issuer1 and to participants and beneficiaries2 7bb7 the median amount charged to such plan or issuer1 and the interquartile range of the costs1 per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 including amounts paid by the participants and beneficiaries1 when the same drug is dispensed by other pharmacies that are not affiliated with or under common ownership with the entity and that are included in the pharmacy network of such plan or coverage2 7cc7 the lowest cost per dosage unit1 per #cj-;day supply and per #ij-;day supply1 for each such drug1 including amounts charged to the plan or coverage and to participants and beneficiaries1 that is available from any pharmacy included in the network of such plan or coverage2 and 7dd7 the net acquisition cost per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 if such drug is subject to a maximum price discount2 and 7,b7 with respect to any group health plan1 including group health insurance coverage offered in connection with such a plan1 regardless of whether the plan or coverage is offered by a specified large employer or whether it is a specified large plan-- 7i7 a summary document for the group health plan that includes such information described in clauses 7i7 through 7iv7 of subparagraph 7,a71 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking71 that the ,secretary determines useful to group health plans for purposes of selecting pharmacy benefit management services1 such as an estimated net price to group health plan and participant or beneficiary1 a cost per claim1 the fee structure or reimbursement model1 and estimated cost per participant or beneficiary2 7ii7 a summary document for plans and issuers to provide to participants and beneficiaries1 which shall be made available to participants or beneficiaries upon request to their group health plan 7including in the case of group health insurance coverage offered in connection with such a plan71 that-- 7,i7 contains such information described in clauses 7iii71 7iv71 7v71 and 7vi71 as applicable1 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking7 that the ,secretary determines useful to participants or beneficiaries in better understanding the plan or coverage or benefits under such plan or coverage2 7,,ii7 contains only aggregate information2 and 7,,iii7 states that participants and beneficiaries may request specific1 claims-level information required to be furnished under subsection 7c7 from the group health plan or health insurance issuer2 and 7iii7 with respect to drugs covered by such plan or coverage during such reporting period-- 7,i7 the total net spending by the plan or coverage for all such drugs2 7,,ii7 the total amount received1 or expected to be received1 by the plan or issuer from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 and 7,,iii7 to the extent feasible1 information on the total amount of remuneration for such drugs1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer7 to participants and beneficiaries2 7iv7 amounts paid directly or indirectly in rebates1 fees1 or any other type of compensation 7as defined in section #djh7;b77#b77;,b77ii77dd77,,aa7 of the ,employee ,retirement ,income ,security ,act7 to brokerage firms1 brokers1 consultants1 advisors1 or any other individual or firm1 for-- 7,i7 the referral of the group health plan's or health insurance issuer's business to an entity providing pharmacy benefit management services1 including the identity of the recipient of such amounts2 7,,ii7 consideration of the entity providing pharmacy benefit management services by the group health plan or health insurance issuer2 or 7,,iii7 the retention of the entity by the group health plan or health insurance issuer2 7v7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in such plan or coverage to fill prescriptions at mail order1 specialty1 or retail pharmacies that are affiliated with or under common ownership with the entity providing pharmacy benefit management services under such plan or coverage1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost-sharing assistance incentives directly or indirectly funded by such entity2 and 7vi7 total gross spending on all drugs under the plan or coverage during the reporting period4 7#c7 ,opt-in for group health insurance coverage offered by a specified large employer or that is a specified large plan ,in the case of group health insurance coverage offered in connection with a group health plan that is offered by a specified large employer or is a specified large plan1 such group health plan may1 on an annual basis1 for plan years beginning on or after the date that is #cj months after the date of enactment of this section1 elect to require an entity providing pharmacy benefit management services on behalf of the health insurance issuer to submit to such group health plan a report that includes all of the information described in paragraph 7#b77;,a71 in addition to the information described in paragraph 7#b77;,b74 7#d7 ,privacy requirements 7,a7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan or a health insurance issuer offering group health insurance coverage shall report information under paragraph 7#a7 in a manner consistent with the privacy regulations promulgated under section #acdjb7;a7 of the ,health ,information ,technology for ,economic and ,clinical ,health ,act and consistent with the privacy regulations promulgated under the ,health ,insurance ,portability and ,accountability ,act of #aiif in part #afj and subparts ,a and ,e of part #afd of title #de1 ,code of ,federal ,regulations 7or successor regulations7 7referred to in this paragraph as the ,,hipaa privacy regulations7 and shall restrict the use and disclosure of such information according to such privacy regulations and such ,,hipaa privacy regulations4 7,b7 ,additional requirements 7i7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage that submits a report under paragraph 7#a7 shall ensure that such report contains only summary health information1 as defined in section #afd4ejd7;a7 of title #de1 ,code of ,federal ,regulations 7or successor regulations74 7ii7 ,restrictions ,in carrying out this subsection1 a group health plan shall comply with section #afd4ejd7;f7 of title #de1 ,code of ,federal ,regulations 7or a successor regulation71 and a plan sponsor shall act in accordance with the terms of the agreement described in such section4 7,c7 ,rule of construction 7i7 ,nothing in this section shall be construed to modify the requirements for the creation1 receipt1 maintenance1 or transmission of protected health information under the ,,hipaa privacy regulations4 7ii7 ,nothing in this section shall be construed to affect the application of any ,federal or ,state privacy or civil rights law1 including the ,,hipaa privacy regulations1 the ,genetic ,information ,nondiscrimination ,act of #bjjh 7,public ,law #aaj-bcc7 7including the amendments made by such ,act71 the ,americans with ,disabilities ,act of #aiij 7#db ,u4,s4,c4 #abaja et sec71 section #ejd of the ,rehabilitation ,act of #aigc 7#bi ,u4,s4,c4 #gid71 section #aeeg of the ,patient ,protection and ,affordable ,care ,act 7#db ,u4,s4,c4 #ahaaf71 title ,,vi of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;d71 and title ,,vii of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;e74 7,d7 ,written notice ,each plan year1 group health plans1 including with respect to group health insurance coverage offered in connection with a group health plan1 shall provide to each participant or beneficiary written notice informing the participant or beneficiary of the requirement for entities providing pharmacy benefit management services on behalf of the group health plan or health insurance issuer offering group health insurance coverage to submit reports to group health plans under paragraph 7#a71 as applicable1 which may include incorporating such notification in plan documents provided to the participant or beneficiary1 or providing individual notification4 7,e7 ,limitation to business associates ,a group health plan receiving a report under paragraph 7#a7 may disclose such information only to the entity from which the report was received or to that entity's business associates as defined in section #afj4ajc of title #de1 ,code of ,federal ,regulations 7or successor regulations7 or as permitted by the ,,hipaa privacy regulations4 7,f7 ,clarification regarding public disclosure of information ,nothing in this section shall prevent an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage1 from placing reasonable restrictions on the public disclosure of the information contained in a report described in paragraph 7#a71 except that such plan1 issuer1 or entity may not-- 7i7 restrict disclosure of such report to the ,department of ,health and ,human ,services1 the ,department of ,labor1 or the ,department of the ,treasury2 or 7ii7 prevent disclosure for the purposes of subsection 7c71 or any other public disclosure requirement under this section4 7,g7 ,limited form of report ,the ,secretary shall define through rulemaking a limited form of the report under paragraph 7#a7 required with respect to any group health plan established by a plan sponsor that is1 or is affiliated with1 a drug manufacturer1 drug wholesaler1 or other direct participant in the drug supply chain1 in order to prevent anti-competitive behavior4 7#e7 ,standard format and regulations 7,a7 ,in general ,not later than #ah months after the date of enactment of this section1 the ,secretary shall specify through rulemaking a standard format for entities providing pharmacy benefit management services on behalf of group health plans and health insurance issuers offering group health insurance coverage1 to submit reports required under paragraph 7#a74 7,b7 ,additional regulations ,not later than #ah months after the date of enactment of this section1 the ,secretary shall1 through rulemaking1 promulgate any other final regulations necessary to implement the requirements of this section4 ,in promulgating such regulations1 the ,secretary shall1 to the extent practicable1 align the reporting requirements under this section with the reporting requirements under section #bgii;,a-#aj4 7c7 ,requirement ,to provide information to participants or beneficiaries ,a group health plan1 including with respect to group health insurance coverage offered in connection with a group health plan1 upon request of a participant or beneficiary1 shall provide to such participant or beneficiary-- 7#a7 the summary document described in subsection 7b77#b77;,b77ii72 and 7#b7 the information described in subsection 7b77#b77;,a77i77,,iii7 with respect to a claim made by or on behalf of such participant or beneficiary4 7d7 ,enforcement 7#a7 ,in general ,the ,secretary shall enforce this section4 ,the enforcement authority under this subsection shall apply only with respect to group health plans 7including group health insurance coverage offered in connection with such a plan7 to which the requirements of subparts ,i and ,,ii of part ,a and part ,d apply in accordance with section #bgbb1 and with respect to entities providing pharmacy benefit management services on behalf of such plans and applicable entities providing services on behalf of such plans4 7#b7 ,failure to provide information ,a group health plan1 a health insurance issuer offering group health insurance coverage1 an entity providing pharmacy benefit management services on behalf of such a plan or issuer1 or an applicable entity providing services on behalf of such a plan or issuer that violates subsection 7a72 an entity providing pharmacy benefit management services on behalf of such a plan or issuer that fails to provide the information required under subsection 7b72 or a group health plan that fails to provide the information required under subsection 7c71 shall be subject to a civil monetary penalty in the amount of #aj1jjj for each day during which such violation continues or such information is not disclosed or reported4 7#c7 ,false information ,a health insurance issuer1 an entity providing pharmacy benefit management services1 or a third party administrator providing services on behalf of such issuer offered by a health insurance issuer that knowingly provides false information under this section shall be subject to a civil monetary penalty in an amount not to exceed #ajj1jjj for each item of false information4 ,such civil monetary penalty shall be in addition to other penalties as may be prescribed by law4 7#d7 ,procedure ,the provisions of section #aabh;,a of the ,social ,security ,act1 other than subsections 7a7 and 7b7 and the first sentence of subsection 7c77#a7 of such section shall apply to civil monetary penalties under this subsection in the same manner as such provisions apply to a penalty or proceeding under such section4 7#e7 ,waivers ,the ,secretary may waive penalties under paragraph 7#b71 or extend the period of time for compliance with a requirement of this section1 for an entity in violation of this section that has made a good-faith effort to comply with the requirements in this section4 7e7 ,rule of construction ,nothing in this section shall be construed to permit a health insurance issuer1 group health plan1 entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer1 or other entity to restrict disclosure to1 or otherwise limit the access of1 the ,secretary to a report described in subsection 7b77#a7 or information related to compliance with subsections 7a71 7b71 7c71 or 7d7 by such issuer1 plan1 or entity4 7f7 ,definitions ,in this section3 7#a7 ,applicable entity ,the term applicable entity means-- 7,a7 an applicable group purchasing organization1 drug manufacturer1 distributor1 wholesaler1 rebate aggregator 7or other purchasing entity designed to aggregate rebates71 or associated third party2 7,b7 any subsidiary1 parent1 affiliate1 or subcontractor of a group health plan1 health insurance issuer1 entity that provides pharmacy benefit management services on behalf of such a plan or issuer1 or any entity described in subparagraph 7,a72 or 7,c7 such other entity as the ,secretary may specify through rulemaking4 7#b7 ,applicable group purchasing organization ,the term applicable group purchasing organization means a group purchasing organization that is affiliated with or under common ownership with an entity providing pharmacy benefit management services4 7#c7 ,contracted compensation ,the term contracted compensation means the sum of any ingredient cost and dispensing fee for a drug 7inclusive of the out-of-pocket costs to the participant or beneficiary71 or another analogous compensation structure that the ,secretary may specify through regulations4 7#d7 ,gross spending ,the term gross spending1 with respect to prescription drug benefits under a group health plan or health insurance coverage1 means the amount spent by a group health plan or health insurance issuer on prescription drug benefits1 calculated before the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#e7 ,net spending ,the term net spending1 with respect to prescription drug benefits under a group health plan or health insurance coverage1 means the amount spent by a group health plan or health insurance issuer on prescription drug benefits1 calculated after the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#f7 ,plan sponsor ,the term plan sponsor has the meaning given such term in section #c7af77;,b7 of the ,employee ,retirement ,income ,security ,act of #aigd4 7#g7 ,remuneration ,the term remuneration has the meaning given such term by the ,secretary through rulemaking1 which shall be reevaluated by the ,secretary every #e years4 7#h7 ,specified large employer ,the term specified large employer means1 in connection with a group health plan 7including group health insurance coverage offered in connection with such a plan7 established or maintained by a single employer1 with respect to a calendar year or a plan year1 as applicable1 an employer who employed an average of at least #ajj employees on business days during the preceding calendar year or plan year and who employs at least #a employee on the first day of the calendar year or plan year4 7#i7 ,specified large plan ,the term specified large plan means a group health plan 7including group health insurance coverage offered in connection with such a plan7 established or maintained by a plan sponsor described in clause 7ii7 or 7iii7 of section #c7af77;,b7 of the ,employee ,retirement ,income ,security ,act of #aigd that had an average of at least #ajj participants on business days during the preceding calendar year or plan year1 as applicable4 7#aj7 ,wholesale acquisition cost ,the term wholesale acquisition cost has the meaning given such term in section #ahdg;,a7c77#f77;,b7 of the ,social ,security ,act4 2 and 7#b7 in section #bgbc 7#db ,u4,s4,c4 #cjj;gg-#bb7-- 7,a7 in subsection 7a7-- 7i7 in paragraph 7#a71 by inserting 7other than section #bgii;,a-#aa7 after part ,d2 and 7ii7 in paragraph 7#b71 by inserting 7other than section #bgii;,a-#aa7 after part ,d2 and 7,b7 in subsection 7b7-- 7i7 in paragraph 7#a71 by inserting 7other than section #bgii;,a-#aa7 after part ,d2 7ii7 in paragraph 7#b77;,a71 by inserting 7other than section #bgii;,a-#aa7 after part ,d2 and 7iii7 in paragraph 7#b77;,c77ii71 by inserting 7other than section #bgii;,a-#aa7 after part ,d4 7b7 ,employee ,retirement ,income ,security ,act of #aigd 7#a7 ,in general ,subtitle ,b of title ,i of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajba et seq47 is amended-- 7,a7 in subpart ,b of part #g 7#bi ,u4,s4,c4 #aahe et seq471 by adding at the end the following3 #gbf4 ,oversight of entities that provide pharmacy benefit management services 7a7 ,in general ,for plan years beginning on or after the date that is #cj months after the date of enactment of this section 7referred to in this subsection and subsection 7b7 as the effective date71 a group health plan or a health insurance issuer offering group health insurance coverage1 or an entity providing pharmacy benefit management services on behalf of such a plan or issuer1 shall not enter into a contract1 including an extension or renewal of a contract1 entered into on or after the effective date1 with an applicable entity unless such applicable entity agrees to-- 7#a7 not limit or delay the disclosure of information to the group health plan 7including such a plan offered through a health insurance issuer7 in such a manner that prevents an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage from making the reports described in subsection 7b72 and 7#b7 provide the entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer relevant information necessary to make the reports described in subsection 7b74 7b7 ,reports 7#a7 ,in general ,for plan years beginning on or after the effective date1 in the case of any contract between a group health plan or a health insurance issuer offering group health insurance coverage offered in connection with such a plan and an entity providing pharmacy benefit management services on behalf of such plan or issuer1 including an extension or renewal of such a contract1 entered into on or after the effective date1 the entity providing pharmacy benefit management services on behalf of such a group health plan or health insurance issuer1 not less frequently than every #f months 7or1 at the request of a group health plan1 not less frequently than quarterly1 and under the same conditions1 terms1 and cost of the semiannual report under this subsection71 shall submit to the group health plan a report in accordance with this section4 ,each such report shall be made available to such group health plan in plain language1 in a machine-readable format1 and as the ,secretary may determine1 other formats4 ,each such report shall include the information described in paragraph 7#b74 7#b7 ,information described ,for purposes of paragraph 7#a71 the information described in this paragraph is1 with respect to drugs covered by a group health plan or group health insurance coverage offered by a health insurance issuer in connection with a group health plan during each reporting period-- 7,a7 in the case of a group health plan that is offered by a specified large employer or that is a specified large plan1 and is not offered as health insurance coverage1 or in the case of health insurance coverage for which the election under paragraph 7#c7 is made for the applicable reporting period-- 7i7 a list of drugs for which a claim was filed and1 with respect to each such drug on such list-- 7,i7 the contracted compensation paid by the group health plan or health insurance issuer for each covered drug 7identified by the ,national ,drug ,code7 to the entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan or health insurance issuer2 7,,ii7 the contracted compensation paid to the pharmacy1 by any entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan or health insurance issuer1 for each covered drug 7identified by the ,national ,drug ,code72 7,,iii7 for each such claim1 the difference between the amount paid under subclause 7,i7 and the amount paid under subclause 7,,ii72 7,,iv7 the proprietary name1 established name or proper name1 and ,national ,drug ,code2 7,v7 for each claim for the drug 7including original prescriptions and refills7 and for each dosage unit of the drug for which a claim was filed1 the type of dispensing channel used to furnish the drug1 including retail1 mail order1 or specialty pharmacy2 7,,vi7 with respect to each drug dispensed1 for each type of dispensing channel 7including retail1 mail order1 or specialty pharmacy7-- 7aa7 whether such drug is a brand name drug or a generic drug1 and-- 7,,aa7 in the case of a brand name drug1 the wholesale acquisition cost1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7,,bb7 in the case of a generic drug1 the average wholesale price1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7bb7 the total number of-- 7,,aa7 prescription claims 7including original prescriptions and refills72 7,,bb7 participants and beneficiaries for whom a claim for such drug was filed through the applicable dispensing channel2 7,,cc7 dosage units and dosage units per fill of such drug2 and 7,,dd7 days supply of such drug per fill2 7,,vii7 the net price per course of treatment or single fill1 such as a #cj-;day supply or #ij-;day supply to the plan or coverage after rebates1 fees1 alternative discounts1 or other remuneration received from applicable entities2 7,,viii7 the total amount of out-of-pocket spending by participants and beneficiaries on such drug1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan or coverage1 or for which no claim is submitted under the plan or coverage2 7,,ix7 the total net spending on the drug2 7,x7 the total amount received1 or expected to be received1 by the plan or issuer from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 7,,xi7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of such drug or spending on such drug2 and 7,,xii7 to the extent feasible1 information on the total amount of remuneration for such drug1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer71 to the participants and beneficiaries enrolled in such plan or coverage2 7ii7 a list of each therapeutic class 7as defined by the ,secretary7 for which a claim was filed under the group health plan or health insurance coverage during the reporting period1 and1 with respect to each such therapeutic class-- 7,i7 the total gross spending on drugs in such class before rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,ii7 the net spending in such class after such rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,iii7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of drugs or drug spending2 7,,iv7 the average net spending per #cj-;day supply and per #ij-;day supply by the plan or by the issuer with respect to such coverage and its participants and beneficiaries1 among all drugs within the therapeutic class for which a claim was filed during the reporting period2 7,v7 the number of participants and beneficiaries who filled a prescription for a drug in such class1 including the ,national ,drug ,code for each such drug2 7,,vi7 if applicable1 a description of the formulary tiers and utilization mechanisms 7such as prior authorization or step therapy7 employed for drugs in that class2 and 7,,vii7 the total out-of-pocket spending under the plan or coverage by participants and beneficiaries1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan or coverage or for which no claim is submitted under the plan or coverage2 7iii7 with respect to any drug for which gross spending under the group health plan or health insurance coverage exceeded #aj1jjj during the reporting period or1 in the case that gross spending under the group health plan or coverage exceeded #aj1jjj during the reporting period with respect to fewer than #ej drugs1 with respect to the #ej prescription drugs with the highest spending during the reporting period-- 7,i7 a list of all other drugs in the same therapeutic class as such drug2 7,,ii7 if applicable1 the rationale for the formulary placement of such drug in that therapeutic category or class1 selected from a list of standard rationales established by the ,secretary1 in consultation with stakeholders2 and 7,,iii7 any change in formulary placement compared to the prior plan year2 and 7iv7 in the case that such plan or issuer 7or an entity providing pharmacy benefit management services on behalf of such plan or issuer7 has an affiliated pharmacy or pharmacy under common ownership1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost sharing assistance incentives funded by an entity providing pharmacy benefit services-- 7,i7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in the plan or coverage to fill prescriptions at mail order1 specialty1 or retail pharmacies2 7,,ii7 the percentage of total prescriptions dispensed by such pharmacies to participants or beneficiaries in such plan or coverage2 and 7,,iii7 a list of all drugs dispensed by such pharmacies to participants or beneficiaries enrolled in such plan or coverage1 and1 with respect to each drug dispensed-- 7aa7 the amount charged1 per dosage unit1 per #cj-;day supply1 or per #ij-;day supply 7as applicable7 to the plan or issuer1 and to participants and beneficiaries2 7bb7 the median amount charged to such plan or issuer1 and the interquartile range of the costs1 per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 including amounts paid by the participants and beneficiaries1 when the same drug is dispensed by other pharmacies that are not affiliated with or under common ownership with the entity and that are included in the pharmacy network of such plan or coverage2 7cc7 the lowest cost per dosage unit1 per #cj-;day supply and per #ij-;day supply1 for each such drug1 including amounts charged to the plan or coverage and to participants and beneficiaries1 that is available from any pharmacy included in the network of such plan or coverage2 and 7dd7 the net acquisition cost per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 if such drug is subject to a maximum price discount2 and 7,b7 with respect to any group health plan1 including group health insurance coverage offered in connection with such a plan1 regardless of whether the plan or coverage is offered by a specified large employer or whether it is a specified large plan-- 7i7 a summary document for the group health plan that includes such information described in clauses 7i7 through 7iv7 of subparagraph 7,a71 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking71 that the ,secretary determines useful to group health plans for purposes of selecting pharmacy benefit management services1 such as an estimated net price to group health plan and participant or beneficiary1 a cost per claim1 the fee structure or reimbursement model1 and estimated cost per participant or beneficiary2 7ii7 a summary document for plans and issuers to provide to participants and beneficiaries1 which shall be made available to participants or beneficiaries upon request to their group health plan 7including in the case of group health insurance coverage offered in connection with such a plan71 that-- 7,i7 contains such information described in clauses 7iii71 7iv71 7v71 and 7vi71 as applicable1 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking7 that the ,secretary determines useful to participants or beneficiaries in better understanding the plan or coverage or benefits under such plan or coverage2 7,,ii7 contains only aggregate information2 and 7,,iii7 states that participants and beneficiaries may request specific1 claims-level information required to be furnished under subsection 7c7 from the group health plan or health insurance issuer2 7iii7 with respect to drugs covered by such plan or coverage during such reporting period-- 7,i7 the total net spending by the plan or coverage for all such drugs2 7,,ii7 the total amount received1 or expected to be received1 by the plan or issuer from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 and 7,,iii7 to the extent feasible1 information on the total amount of remuneration for such drugs1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer7 to participants and beneficiaries2 7iv7 amounts paid directly or indirectly in rebates1 fees1 or any other type of compensation 7as defined in section #djh7;b77#b77;,b77ii77dd77,,aa77 to brokerage firms1 brokers1 consultants1 advisors1 or any other individual or firm1 for-- 7,i7 the referral of the group health plan's or health insurance issuer's business to an entity providing pharmacy benefit management services1 including the identity of the recipient of such amounts2 7,,ii7 consideration of the entity providing pharmacy benefit management services by the group health plan or health insurance issuer2 or 7,,iii7 the retention of the entity by the group health plan or health insurance issuer2 7v7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in such plan or coverage to fill prescriptions at mail order1 specialty1 or retail pharmacies that are affiliated with or under common ownership with the entity providing pharmacy benefit management services under such plan or coverage1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost-sharing assistance incentives directly or indirectly funded by such entity2 and 7vi7 total gross spending on all drugs under the plan or coverage during the reporting period4 7#c7 ,opt-in for group health insurance coverage offered by a specified large employer or that is a specified large plan ,in the case of group health insurance coverage offered in connection with a group health plan that is offered by a specified large employer or is a specified large plan1 such group health plan may1 on an annual basis1 for plan years beginning on or after the date that is #cj months after the date of enactment of this section1 elect to require an entity providing pharmacy benefit management services on behalf of the health insurance issuer to submit to such group health plan a report that includes all of the information described in paragraph 7#b77;,a71 in addition to the information described in paragraph 7#b77;,b74 7#d7 ,privacy requirements 7,a7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan or a health insurance issuer offering group health insurance coverage shall report information under paragraph 7#a7 in a manner consistent with the privacy regulations promulgated under section #acdjb7;a7 of the ,health ,information ,technology for ,economic and ,clinical ,health ,act 7#db ,u4,s4,c4 #agicb7;a77 and consistent with the privacy regulations promulgated under the ,health ,insurance ,portability and ,accountability ,act of #aiif in part #afj and subparts ,a and ,e of part #afd of title #de1 ,code of ,federal ,regulations 7or successor regulations7 7referred to in this paragraph as the ,,hipaa privacy regulations7 and shall restrict the use and disclosure of such information according to such privacy regulations and such ,,hipaa privacy regulations4 7,b7 ,additional requirements 7i7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage that submits a report under paragraph 7#a7 shall ensure that such report contains only summary health information1 as defined in section #afd4ejd7;a7 of title #de1 ,code of ,federal ,regulations 7or successor regulations74 7ii7 ,restrictions ,in carrying out this subsection1 a group health plan shall comply with section #afd4ejd7;f7 of title #de1 ,code of ,federal ,regulations 7or a successor regulation71 and a plan sponsor shall act in accordance with the terms of the agreement described in such section4 7,c7 ,rule of construction 7i7 ,nothing in this section shall be construed to modify the requirements for the creation1 receipt1 maintenance1 or transmission of protected health information under the ,,hipaa privacy regulations4 7ii7 ,nothing in this section shall be construed to affect the application of any ,federal or ,state privacy or civil rights law1 including the ,,hipaa privacy regulations1 the ,genetic ,information ,nondiscrimination ,act of #bjjh 7,public ,law #aaj-bcc7 7including the amendments made by such ,act71 the ,americans with ,disabilities ,act of #aiij 7#db ,u4,s4,c4 #abaja et sec71 section #ejd of the ,rehabilitation ,act of #aigc 7#bi ,u4,s4,c4 #gid71 section #aeeg of the ,patient ,protection and ,affordable ,care ,act 7#db ,u4,s4,c4 #ahaaf71 title ,,vi of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;d71 and title ,,vii of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;e74 7,d7 ,written notice ,each plan year1 group health plans1 including with respect to group health insurance coverage offered in connection with a group health plan1 shall provide to each participant or beneficiary written notice informing the participant or beneficiary of the requirement for entities providing pharmacy benefit management services on behalf of the group health plan or health insurance issuer offering group health insurance coverage to submit reports to group health plans under paragraph 7#a71 as applicable1 which may include incorporating such notification in plan documents provided to the participant or beneficiary1 or providing individual notification4 7,e7 ,limitation to business associates ,a group health plan receiving a report under paragraph 7#a7 may disclose such information only to the entity from which the report was received or to that entity's business associates as defined in section #afj4ajc of title #de1 ,code of ,federal ,regulations 7or successor regulations7 or as permitted by the ,,hipaa privacy regulations4 7,f7 ,clarification regarding public disclosure of information ,nothing in this section shall prevent an entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer offering group health insurance coverage1 from placing reasonable restrictions on the public disclosure of the information contained in a report described in paragraph 7#a71 except that such plan1 issuer1 or entity may not-- 7i7 restrict disclosure of such report to the ,department of ,health and ,human ,services1 the ,department of ,labor1 or the ,department of the ,treasury2 or 7ii7 prevent disclosure for the purposes of subsection 7c71 or any other public disclosure requirement under this section4 7,g7 ,limited form of report ,the ,secretary shall define through rulemaking a limited form of the report under paragraph 7#a7 required with respect to any group health plan established by a plan sponsor that is1 or is affiliated with1 a drug manufacturer1 drug wholesaler1 or other direct participant in the drug supply chain1 in order to prevent anti-competitive behavior4 7#e7 ,standard format and regulations 7,a7 ,in general ,not later than #ah months after the date of enactment of this section1 the ,secretary shall specify through rulemaking a standard format for entities providing pharmacy benefit management services on behalf of group health plans and health insurance issuers offering group health insurance coverage1 to submit reports required under paragraph 7#a74 7,b7 ,additional regulations ,not later than #ah months after the date of enactment of this section1 the ,secretary shall1 through rulemaking1 promulgate any other final regulations necessary to implement the requirements of this section4 ,in promulgating such regulations1 the ,secretary shall1 to the extent practicable1 align the reporting requirements under this section with the reporting requirements under section #gbe4 7c7 ,requirement ,to provide information to participants or beneficiaries ,a group health plan1 including with respect to group health insurance coverage offered in connection with a group health plan1 upon request of a participant or beneficiary1 shall provide to such participant or beneficiary-- 7#a7 the summary document described in subsection 7b77#b77;,b77ii72 and 7#b7 the information described in subsection 7b77#b77;,a77i77,,iii7 with respect to a claim made by or on behalf of such participant or beneficiary4 7d7 ,rule of construction ,nothing in this section shall be construed to permit a health insurance issuer1 group health plan1 entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer1 or other entity to restrict disclosure to1 or otherwise limit the access of1 the ,secretary to a report described in subsection 7b77#a7 or information related to compliance with subsections 7a71 7b71 or 7c7 of this section or section #ejb7;c77#ac7 by such issuer1 plan1 or entity4 7e7 ,definitions ,in this section3 7#a7 ,applicable entity ,the term applicable entity means-- 7,a7 an applicable group purchasing organization1 drug manufacturer1 distributor1 wholesaler1 rebate aggregator 7or other purchasing entity designed to aggregate rebates71 or associated third party2 7,b7 any subsidiary1 parent1 affiliate1 or subcontractor of a group health plan1 health insurance issuer1 entity that provides pharmacy benefit management services on behalf of such a plan or issuer1 or any entity described in subparagraph 7,a72 or 7,c7 such other entity as the ,secretary may specify through rulemaking4 7#b7 ,applicable group purchasing organization ,the term applicable group purchasing organization means a group purchasing organization that is affiliated with or under common ownership with an entity providing pharmacy benefit management services4 7#c7 ,contracted compensation ,the term contracted compensation means the sum of any ingredient cost and dispensing fee for a drug 7inclusive of the out-of-pocket costs to the participant or beneficiary71 or another analogous compensation structure that the ,secretary may specify through regulations4 7#d7 ,gross spending ,the term gross spending1 with respect to prescription drug benefits under a group health plan or health insurance coverage1 means the amount spent by a group health plan or health insurance issuer on prescription drug benefits1 calculated before the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#e7 ,net spending ,the term net spending1 with respect to prescription drug benefits under a group health plan or health insurance coverage1 means the amount spent by a group health plan or health insurance issuer on prescription drug benefits1 calculated after the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#f7 ,plan sponsor ,the term plan sponsor has the meaning given such term in section #c7af77;,b74 7#g7 ,remuneration ,the term remuneration has the meaning given such term by the ,secretary through rulemaking1 which shall be reevaluated by the ,secretary every #e years4 7#h7 ,specified large employer ,the term specified large employer means1 in connection with a group health plan 7including group health insurance coverage offered in connection with such a plan7 established or maintained by a single employer1 with respect to a calendar year or a plan year1 as applicable1 an employer who employed an average of at least #ajj employees on business days during the preceding calendar year or plan year and who employs at least #a employee on the first day of the calendar year or plan year4 7#i7 ,specified large plan ,the term specified large plan means a group health plan 7including group health insurance coverage offered in connection with such a plan7 established or maintained by a plan sponsor described in clause 7ii7 or 7iii7 of section #c7af77;,b7 that had an average of at least #ajj participants on business days during the preceding calendar year or plan year1 as applicable4 7#aj7 ,wholesale acquisition cost ,the term wholesale acquisition cost has the meaning given such term in section #ahdg;,a7c77#f77;,b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#c;a7c77#f77;,b774 2 7,b7 in section #ejb 7#bi ,u4,s4,c4 #aacb7-- 7i7 in subsection 7a77#f71 by striking or 7#i7 and inserting 7#i71 or 7#ac72 7ii7 in subsection 7b77#c71 by striking under subsection 7c77#i7 and inserting under paragraphs 7#i7 and 7#ac7 of subsection 7c72 and 7iii7 in subsection 7c71 by adding at the end the following3 7#ac7 ,secretarial enforcement authority relating to oversight of pharmacy benefit management services 7,a7 ,failure to provide information ,the ,secretary may impose a penalty against a plan administrator of a group health plan1 a health insurance issuer offering group health insurance coverage1 or an entity providing pharmacy benefit management services on behalf of such a plan or issuer1 or an applicable entity 7as defined in section #gbf7;f77 that violates section #gbf7;a72 an entity providing pharmacy benefit management services on behalf of such a plan or issuer that fails to provide the information required under section #gbf7;b72 or any person who causes a group health plan to fail to provide the information required under section #gbf7;c71 in the amount of #aj1jjj for each day during which such violation continues or such information is not disclosed or reported4 7,b7 ,false information ,the ,secretary may impose a penalty against a plan administrator of a group health plan1 a health insurance issuer offering group health insurance coverage1 an entity providing pharmacy benefit management services1 or an applicable entity 7as defined in section #gbf7;f77 that knowingly provides false information under section #gbf1 in an amount not to exceed #ajj1jjj for each item of false information4 ,such penalty shall be in addition to other penalties as may be prescribed by law4 7,c7 ,waivers ,the ,secretary may waive penalties under subparagraph 7,a71 or extend the period of time for compliance with a requirement of this section1 for an entity in violation of section #gbf that has made a good-faith effort to comply with the requirements of section #gbf4 2 and 7,c7 in section #gcb7;a7 7#bi ,u4,s4,c4 #aaia;a7a771 by striking section #gaa and inserting sections #gaa and #gbf4 7#b7 ,clerical amendment ,the table of contents in section #a of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajja et seq47 is amended by inserting after the item relating to section #gbe the following new item3 ,sec4 #gbf4 ,oversight of entities that provide pharmacy benefit management services4 4 7c7 ,internal ,revenue ,code of #aihf 7#a7 ,in general ,chapter #ajj of the ,internal ,revenue ,code of #aihf is amended-- 7,a7 by adding at the end of subchapter ,b the following3 #ihbf4 ,oversight of entities that provide pharmacy benefit management services 7a7 ,in general ,for plan years beginning on or after the date that is #cj months after the date of enactment of this section 7referred to in this subsection and subsection 7b7 as the effective date71 a group health plan1 or an entity providing pharmacy benefit management services on behalf of such a plan1 shall not enter into a contract1 including an extension or renewal of a contract1 entered into on or after the effective date1 with an applicable entity unless such applicable entity agrees to-- 7#a7 not limit or delay the disclosure of information to the group health plan in such a manner that prevents an entity providing pharmacy benefit management services on behalf of a group health plan from making the reports described in subsection 7b72 and 7#b7 provide the entity providing pharmacy benefit management services on behalf of a group health plan relevant information necessary to make the reports described in subsection 7b74 7b7 ,reports 7#a7 ,in general ,for plan years beginning on or after the effective date1 in the case of any contract between a group health plan and an entity providing pharmacy benefit management services on behalf of such plan1 including an extension or renewal of such a contract1 entered into on or after the effective date1 the entity providing pharmacy benefit management services on behalf of such a group health plan1 not less frequently than every #f months 7or1 at the request of a group health plan1 not less frequently than quarterly1 and under the same conditions1 terms1 and cost of the semiannual report under this subsection71 shall submit to the group health plan a report in accordance with this section4 ,each such report shall be made available to such group health plan in plain language1 in a machine-readable format1 and as the ,secretary may determine1 other formats4 ,each such report shall include the information described in paragraph 7#b74 7#b7 ,information described ,for purposes of paragraph 7#a71 the information described in this paragraph is1 with respect to drugs covered by a group health plan during each reporting period-- 7,a7 in the case of a group health plan that is offered by a specified large employer or that is a specified large plan1 and is not offered as health insurance coverage1 or in the case of health insurance coverage for which the election under paragraph 7#c7 is made for the applicable reporting period-- 7i7 a list of drugs for which a claim was filed and1 with respect to each such drug on such list-- 7,i7 the contracted compensation paid by the group health plan for each covered drug 7identified by the ,national ,drug ,code7 to the entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan2 7,,ii7 the contracted compensation paid to the pharmacy1 by any entity providing pharmacy benefit management services or other applicable entity on behalf of the group health plan1 for each covered drug 7identified by the ,national ,drug ,code72 7,,iii7 for each such claim1 the difference between the amount paid under subclause 7,i7 and the amount paid under subclause 7,,ii72 7,,iv7 the proprietary name1 established name or proper name1 and ,national ,drug ,code2 7,v7 for each claim for the drug 7including original prescriptions and refills7 and for each dosage unit of the drug for which a claim was filed1 the type of dispensing channel used to furnish the drug1 including retail1 mail order1 or specialty pharmacy2 7,,vi7 with respect to each drug dispensed1 for each type of dispensing channel 7including retail1 mail order1 or specialty pharmacy7-- 7aa7 whether such drug is a brand name drug or a generic drug1 and-- 7,,aa7 in the case of a brand name drug1 the wholesale acquisition cost1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7,,bb7 in the case of a generic drug1 the average wholesale price1 listed as cost per days supply and cost per dosage unit1 on the date such drug was dispensed2 and 7bb7 the total number of-- 7,,aa7 prescription claims 7including original prescriptions and refills72 7,,bb7 participants and beneficiaries for whom a claim for such drug was filed through the applicable dispensing channel2 7,,cc7 dosage units and dosage units per fill of such drug2 and 7,,dd7 days supply of such drug per fill2 7,,vii7 the net price per course of treatment or single fill1 such as a #cj-;day supply or #ij-;day supply to the plan after rebates1 fees1 alternative discounts1 or other remuneration received from applicable entities2 7,,viii7 the total amount of out-of-pocket spending by participants and beneficiaries on such drug1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan1 or for which no claim is submitted under the plan2 7,,ix7 the total net spending on the drug2 7,x7 the total amount received1 or expected to be received1 by the plan from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 7,,xi7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of such drug or spending on such drug2 and 7,,xii7 to the extent feasible1 information on the total amount of remuneration for such drug1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer71 to the participants and beneficiaries enrolled in such plan2 7ii7 a list of each therapeutic class 7as defined by the ,secretary7 for which a claim was filed under the group health plan during the reporting period1 and1 with respect to each such therapeutic class-- 7,i7 the total gross spending on drugs in such class before rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,ii7 the net spending in such class after such rebates1 price concessions1 alternative discounts1 or other remuneration from applicable entities2 7,,iii7 the total amount received1 or expected to be received1 by the entity providing pharmacy benefit management services1 from applicable entities1 in rebates1 fees1 alternative discounts1 or other remuneration from such entities-- 7aa7 for claims incurred during the reporting period2 and 7bb7 that is related to utilization of drugs or drug spending2 7,,iv7 the average net spending per #cj-;day supply and per #ij-;day supply by the plan and its participants and beneficiaries1 among all drugs within the therapeutic class for which a claim was filed during the reporting period2 7,v7 the number of participants and beneficiaries who filled a prescription for a drug in such class1 including the ,national ,drug ,code for each such drug2 7,,vi7 if applicable1 a description of the formulary tiers and utilization mechanisms 7such as prior authorization or step therapy7 employed for drugs in that class2 and 7,,vii7 the total out-of-pocket spending under the plan by participants and beneficiaries1 including spending through copayments1 coinsurance1 and deductibles1 but not including any amounts spent by participants and beneficiaries on drugs not covered under the plan or for which no claim is submitted under the plan2 7iii7 with respect to any drug for which gross spending under the group health plan exceeded #aj1jjj during the reporting period or1 in the case that gross spending under the group health plan exceeded #aj1jjj during the reporting period with respect to fewer than #ej drugs1 with respect to the #ej prescription drugs with the highest spending during the reporting period-- 7,i7 a list of all other drugs in the same therapeutic class as such drug2 7,,ii7 if applicable1 the rationale for the formulary placement of such drug in that therapeutic category or class1 selected from a list of standard rationales established by the ,secretary1 in consultation with stakeholders2 and 7,,iii7 any change in formulary placement compared to the prior plan year2 and 7iv7 in the case that such plan 7or an entity providing pharmacy benefit management services on behalf of such plan7 has an affiliated pharmacy or pharmacy under common ownership1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost sharing assistance incentives funded by an entity providing pharmacy benefit services-- 7,i7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in the plan to fill prescriptions at mail order1 specialty1 or retail pharmacies2 7,,ii7 the percentage of total prescriptions dispensed by such pharmacies to participants or beneficiaries in such plan2 and 7,,iii7 a list of all drugs dispensed by such pharmacies to participants or beneficiaries enrolled in such plan1 and1 with respect to each drug dispensed-- 7aa7 the amount charged1 per dosage unit1 per #cj-;day supply1 or per #ij-;day supply 7as applicable7 to the plan1 and to participants and beneficiaries2 7bb7 the median amount charged to such plan1 and the interquartile range of the costs1 per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 including amounts paid by the participants and beneficiaries1 when the same drug is dispensed by other pharmacies that are not affiliated with or under common ownership with the entity and that are included in the pharmacy network of such plan2 7cc7 the lowest cost per dosage unit1 per #cj-;day supply and per #ij-;day supply1 for each such drug1 including amounts charged to the plan and to participants and beneficiaries1 that is available from any pharmacy included in the network of such plan2 and 7dd7 the net acquisition cost per dosage unit1 per #cj-;day supply1 and per #ij-;day supply1 if such drug is subject to a maximum price discount2 and 7,b7 with respect to any group health plan1 regardless of whether the plan is offered by a specified large employer or whether it is a specified large plan-- 7i7 a summary document for the group health plan that includes such information described in clauses 7i7 through 7iv7 of subparagraph 7,a71 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking71 that the ,secretary determines useful to group health plans for purposes of selecting pharmacy benefit management services1 such as an estimated net price to group health plan and participant or beneficiary1 a cost per claim1 the fee structure or reimbursement model1 and estimated cost per participant or beneficiary2 7ii7 a summary document for plans to provide to participants and beneficiaries1 which shall be made available to participants or beneficiaries upon request to their group health plan1 that-- 7,i7 contains such information described in clauses 7iii71 7iv71 7v71 and 7vi71 as applicable1 as specified by the ,secretary through guidance1 program instruction1 or otherwise 7with no requirement of notice and comment rulemaking7 that the ,secretary determines useful to participants or beneficiaries in better understanding the plan or benefits under such plan2 7,,ii7 contains only aggregate information2 and 7,,iii7 states that participants and beneficiaries may request specific1 claims-level information required to be furnished under subsection 7c7 from the group health plan2 and 7iii7 with respect to drugs covered by such plan during such reporting period-- 7,i7 the total net spending by the plan for all such drugs2 7,,ii7 the total amount received1 or expected to be received1 by the plan from any applicable entity in rebates1 fees1 alternative discounts1 or other remuneration2 and 7,,iii7 to the extent feasible1 information on the total amount of remuneration for such drugs1 including copayment assistance dollars paid1 copayment cards applied1 or other discounts provided by each drug manufacturer 7or entity administering copayment assistance on behalf of such drug manufacturer7 to participants and beneficiaries2 7iv7 amounts paid directly or indirectly in rebates1 fees1 or any other type of compensation 7as defined in section #djh7;b77#b77;,b77ii77dd77,,aa7 of the ,employee ,retirement ,income ,security ,act 7#bi ,u4,s4,c4 #aajh7;b77#b77;,b77ii77dd77,,aa777 to brokerage firms1 brokers1 consultants1 advisors1 or any other individual or firm1 for-- 7,i7 the referral of the group health plan's business to an entity providing pharmacy benefit management services1 including the identity of the recipient of such amounts2 7,,ii7 consideration of the entity providing pharmacy benefit management services by the group health plan2 or 7,,iii7 the retention of the entity by the group health plan2 7v7 an explanation of any benefit design parameters that encourage or require participants and beneficiaries in such plan to fill prescriptions at mail order1 specialty1 or retail pharmacies that are affiliated with or under common ownership with the entity providing pharmacy benefit management services under such plan1 including mandatory mail and specialty home delivery programs1 retail and mail auto-refill programs1 and cost-sharing assistance incentives directly or indirectly funded by such entity2 and 7vi7 total gross spending on all drugs under the plan during the reporting period4 7#c7 ,opt-in for group health insurance coverage offered by a specified large employer or that is a specified large plan ,in the case of group health insurance coverage offered in connection with a group health plan that is offered by a specified large employer or is a specified large plan1 such group health plan may1 on an annual basis1 for plan years beginning on or after the date that is #cj months after the date of enactment of this section1 elect to require an entity providing pharmacy benefit management services on behalf of the health insurance issuer to submit to such group health plan a report that includes all of the information described in paragraph 7#b77;,a71 in addition to the information described in paragraph 7#b77;,b74 7#d7 ,privacy requirements 7,a7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan shall report information under paragraph 7#a7 in a manner consistent with the privacy regulations promulgated under section #acdjb7;a7 of the ,health ,information ,technology for ,economic and ,clinical ,health ,act 7#db ,u4,s4,c4 #agicb7;a77 and consistent with the privacy regulations promulgated under the ,health ,insurance ,portability and ,accountability ,act of #aiif in part #afj and subparts ,a and ,e of part #afd of title #de1 ,code of ,federal ,regulations 7or successor regulations7 7referred to in this paragraph as the ,,hipaa privacy regulations7 and shall restrict the use and disclosure of such information according to such privacy regulations and such ,,hipaa privacy regulations4 7,b7 ,additional requirements 7i7 ,in general ,an entity providing pharmacy benefit management services on behalf of a group health plan that submits a report under paragraph 7#a7 shall ensure that such report contains only summary health information1 as defined in section #afd4ejd7;a7 of title #de1 ,code of ,federal ,regulations 7or successor regulations74 7ii7 ,restrictions ,in carrying out this subsection1 a group health plan shall comply with section #afd4ejd7;f7 of title #de1 ,code of ,federal ,regulations 7or a successor regulation71 and a plan sponsor shall act in accordance with the terms of the agreement described in such section4 7,c7 ,rule of construction 7i7 ,nothing in this section shall be construed to modify the requirements for the creation1 receipt1 maintenance1 or transmission of protected health information under the ,,hipaa privacy regulations4 7ii7 ,nothing in this section shall be construed to affect the application of any ,federal or ,state privacy or civil rights law1 including the ,,hipaa privacy regulations1 the ,genetic ,information ,nondiscrimination ,act of #bjjh 7,public ,law #aaj-bcc7 7including the amendments made by such ,act71 the ,americans with ,disabilities ,act of #aiij 7#db ,u4,s4,c4 #abaja et sec71 section #ejd of the ,rehabilitation ,act of #aigc 7#bi ,u4,s4,c4 #gid71 section #aeeg of the ,patient ,protection and ,affordable ,care ,act 7#db ,u4,s4,c4 #ahaaf71 title ,,vi of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;d71 and title ,,vii of the ,civil ,rights ,act of #aifd 7#db ,u4,s4,c4 #bjjj;e74 7,d7 ,written notice ,each plan year1 group health plans shall provide to each participant or beneficiary written notice informing the participant or beneficiary of the requirement for entities providing pharmacy benefit management services on behalf of the group health plan to submit reports to group health plans under paragraph 7#a71 as applicable1 which may include incorporating such notification in plan documents provided to the participant or beneficiary1 or providing individual notification4 7,e7 ,limitation to business associates ,a group health plan receiving a report under paragraph 7#a7 may disclose such information only to the entity from which the report was received or to that entity's business associates as defined in section #afj4ajc of title #de1 ,code of ,federal ,regulations 7or successor regulations7 or as permitted by the ,,hipaa privacy regulations4 7,f7 ,clarification regarding public disclosure of information ,nothing in this section shall prevent an entity providing pharmacy benefit management services on behalf of a group health plan1 from placing reasonable restrictions on the public disclosure of the information contained in a report described in paragraph 7#a71 except that such plan or entity may not-- 7i7 restrict disclosure of such report to the ,department of ,health and ,human ,services1 the ,department of ,labor1 or the ,department of the ,treasury2 or 7ii7 prevent disclosure for the purposes of subsection 7c71 or any other public disclosure requirement under this section4 7,g7 ,limited form of report ,the ,secretary shall define through rulemaking a limited form of the report under paragraph 7#a7 required with respect to any group health plan established by a plan sponsor that is1 or is affiliated with1 a drug manufacturer1 drug wholesaler1 or other direct participant in the drug supply chain1 in order to prevent anti-competitive behavior4 7#e7 ,standard format and regulations 7,a7 ,in general ,not later than #ah months after the date of enactment of this section1 the ,secretary shall specify through rulemaking a standard format for entities providing pharmacy benefit management services on behalf of group health plans1 to submit reports required under paragraph 7#a74 7,b7 ,additional regulations ,not later than #ah months after the date of enactment of this section1 the ,secretary shall1 through rulemaking1 promulgate any other final regulations necessary to implement the requirements of this section4 ,in promulgating such regulations1 the ,secretary shall1 to the extent practicable1 align the reporting requirements under this section with the reporting requirements under section #ihbe4 7c7 ,requirement ,to provide information to participants or beneficiaries ,a group health plan1 upon request of a participant or beneficiary1 shall provide to such participant or beneficiary-- 7#a7 the summary document described in subsection 7b77#b77;,b77ii72 and 7#b7 the information described in subsection 7b77#b77;,a77i77,,iii7 with respect to a claim made by or on behalf of such participant or beneficiary4 7d7 ,rule of construction ,nothing in this section shall be construed to permit a health insurance issuer1 group health plan1 entity providing pharmacy benefit management services on behalf of a group health plan or health insurance issuer1 or other entity to restrict disclosure to1 or otherwise limit the access of1 the ,secretary to a report described in subsection 7b77#a7 or information related to compliance with subsections 7a71 7b71 or 7c7 of this section or section #dihj;,d7g7 by such issuer1 plan1 or entity4 7e7 ,definitions ,in this section3 7#a7 ,applicable entity ,the term applicable entity means-- 7,a7 an applicable group purchasing organization1 drug manufacturer1 distributor1 wholesaler1 rebate aggregator 7or other purchasing entity designed to aggregate rebates71 or associated third party2 7,b7 any subsidiary1 parent1 affiliate1 or subcontractor of a group health plan1 health insurance issuer1 entity that provides pharmacy benefit management services on behalf of such a plan or issuer1 or any entity described in subparagraph 7,a72 or 7,c7 such other entity as the ,secretary may specify through rulemaking4 7#b7 ,applicable group purchasing organization ,the term applicable group purchasing organization means a group purchasing organization that is affiliated with or under common ownership with an entity providing pharmacy benefit management services4 7#c7 ,contracted compensation ,the term contracted compensation means the sum of any ingredient cost and dispensing fee for a drug 7inclusive of the out-of-pocket costs to the participant or beneficiary71 or another analogous compensation structure that the ,secretary may specify through regulations4 7#d7 ,gross spending ,the term gross spending1 with respect to prescription drug benefits under a group health plan1 means the amount spent by a group health plan on prescription drug benefits1 calculated before the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#e7 ,net spending ,the term net spending1 with respect to prescription drug benefits under a group health plan1 means the amount spent by a group health plan on prescription drug benefits1 calculated after the application of rebates1 fees1 alternative discounts1 or other remuneration4 7#f7 ,plan sponsor ,the term plan sponsor has the meaning given such term in section #c7af77;,b7 of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajjb7af77;,b774 7#g7 ,remuneration ,the term remuneration has the meaning given such term by the ,secretary1 through rulemaking1 which shall be reevaluated by the ,secretary every #e years4 7#h7 ,specified large employer ,the term specified large employer means1 in connection with a group health plan established or maintained by a single employer1 with respect to a calendar year or a plan year1 as applicable1 an employer who employed an average of at least #ajj employees on business days during the preceding calendar year or plan year and who employs at least #a employee on the first day of the calendar year or plan year4 7#i7 ,specified large plan ,the term specified large plan means a group health plan established or maintained by a plan sponsor described in clause 7ii7 or 7iii7 of section #c7af77;,b7 of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #ajjb7af77;,b77 that had an average of at least #ajj participants on business days during the preceding calendar year or plan year1 as applicable4 7#aj7 ,wholesale acquisition cost ,the term wholesale acquisition cost has the meaning given such term in section #ahdg;,a7c77#f77;,b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#c;a7c77#f77;,b774 2 7#b7 ,exception for certain group health plans ,section #ihca7;a77#b7 of the ,internal ,revenue ,code of #aihf is amended by inserting other than with respect to section #ihbf1 before any group health plan4 7#c7 ,enforcement ,section #dihj;,d of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new subsection3 7g7 ,application to requirements imposed on certain entities providing pharmacy benefit management services ,in the case of any requirement under section #ihbf that applies with respect to an entity providing pharmacy benefit management services on behalf of a group health plan1 any reference in this section to such group health plan 7and the reference in subsection 7e77#a7 to the employer7 shall be treated as including a reference to such entity4 4 7#d7 ,clerical amendment ,the table of sections for subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new item3 ,sec4 #ihbf4 ,oversight of entities that provide pharmacy benefit management services44